Several methods have been proposed in the recent years to quantitate d
yspnoea in healthy subjects or patients. Dyspnoea can be serially asse
ssed on exercise, using either a visual analogue scale or a Borg scale
, and is usually analyzed in relation to ventilation, which defines a
dyspnoea threshold and a dyspnoea/ventilation slope. Inhaled bronchodi
lators, oral morphine, continuous (or inspiratory) positive airway pre
ssure or respiratory rehabilitation programmes are able to decrease th
e dyspnoea/ventilation slope in patients with chronic obstructive pulm
onary disease, while atenolol and pneumectomy have a deleterious effec
t. Measurement of dyspnoea in everyday life is feasible using the oxyg
en cost diagram or the baseline dyspnoea index; these indices are resp
onsive to therapy, e.g. to oral theophylline in patients with chronic
obstructive pulmonary disease. Dyspnoea measured at rest is a marker f
or evaluating the perception of added loads (open scale) or acute bron
choconstriction in normals or patients; in the latter it may also refl
ect the perception of the degree in baseline ventilatory impairment or
that of acute bronchodilation (bipolar visual analogue scale). Some r
espiratory patients being poor perceivers, methods able to improve the
perception of airway obstruction are desirable in these individuals.